Keyword: Hospira

Pfizer saw double-digit growth in its sterile injectables portfolio after a yearslong effort to bring that business up to regulator muster.

Abbott helmsman Miles White, who oversaw the spinoffs of AbbVie and Hospira, will step down as CEO after 21 years at the top job.

Catalent has invested $9 million in a clinical supply facility and Sagent has access to expanded manufacturing in Canada.

Swine fever in China has forced one of the largest manufacturers of heparin to begin limiting allocations of the treatment.

Mylan is recalling a chemo drug and Hospira a commonly used solution because potentially dangerous particulate has been discovered in vials.

Pfizer is closing a Hospira plant in India, but the FDA still issued a warning letter for a list of serious violations it uncovered last year.

Pfizer is offering some 1,700 door-heading employees "an attractive financial scheme that is significantly higher than the legal requirements."

Pfizer's plan to close two legacy Hospira plants in India puts 1,700 jobs stationed there at risk.

The FDA’s Center for Veterinary Medicine has reached an agreement for Pfizer to divert part of a new source of injected pain drugs to veterinarians.

The most recent inspection of Pfizer's troubled injectables plant in McPherson, Kansas, found eight observations, seven of them repeats.